- Home
- / CordenPharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
CordenPharma financials data including stock price, CreditSafe score, income statement, and balance sheet.
Revenue
$16.2 M
FY, 2020
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
| Revenue | 13.0M | 14.2M | 16.2M |
| Revenue growth, % | 8.8% | -99.9% | |
| Cost of goods sold | 1.2M | 414.0K | 236.0K |
| Gross profit | 11.8M | 13.8M | 16.0M |
| Gross profit margin, % | 90.7% | 97.1% | 98.5% |
| General and administrative expense | 2.6M | 3.0M | 2.6M |
| Operating expense total | 12.5M | 13.9M | 15.7M |
| Depreciation and amortization | 167.0K | 175.0K | 167.0K |
| Interest expense | 42.0K | 37.0K | 34.0K |
| Pre tax profit | (318.0K) | (17.0K) | 592.0K |
| Income tax expense | (21.0K) | 8.0K | 99.0K |
| Net Income | (298.0K) | (26.0K) | 493.0K |